Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.77 |
| ▸ | HTT | P42858 | 1/20 | 0.77 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 6/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ACP1 | P24666 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3244369 | 0.87 | SMN1; SMN2 (1.00) | SMN1; SMN2HTTRIPK1RAB9ANPC1 | |
| SCHEMBL2172967 | 0.87 | SMN1; SMN2 (0.75) | SMN1; SMN2HTTRIPK1RAB9ANPC1 | |
| SCHEMBL14538999 | 0.84 | SMN1; SMN2 (0.59) | SMN1; SMN2HTTRAB9ANPC1MAPT | |
| SCHEMBL29197494 | 0.82 | HTT (0.56) | SMN1; SMN2HTTRIPK1RAB9ANPC1 | |
| SCHEMBL30050685 | 0.82 | HTT (0.56) | SMN1; SMN2HTTRIPK1RAB9ANPC1 | |
| SCHEMBL23926457 | 0.81 | RIPK1 (0.53) | SMN1; SMN2HTTRIPK1RAB9ANPC1 | |
| SCHEMBL29361660 | 0.80 | RIPK1 (0.52) | SMN1; SMN2HTTRIPK1RAB9ANPC1 | |
| SCHEMBL2002714 | 0.80 | RIPK1 (0.52) | SMN1; SMN2HTTRIPK1RAB9ANPC1 | |
| SCHEMBL31219335 | 0.80 | ALDH1A1 (0.77) | SMN1; SMN2HTTRIPK1MAPTALDH1A1 | |
| SCHEMBL617121 | 0.80 | RIPK1 (0.52) | SMN1; SMN2HTTRIPK1RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115976586-B | Forward and reverse pulse electrolytic nickel-tungsten alloy solution, preparation method, electroplating method and nickel-tungsten alloy coating | 昆山一鼎工业科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-115976586-A | Positive and negative pulse electrolytic nickel-tungsten alloy solution, preparation method, electroplating method and nickel-tungsten alloy coating | 昆山一鼎工业科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-115976586-B | Forward and reverse pulse electrolytic nickel-tungsten alloy solution, preparation method, electroplating method and nickel-tungsten alloy coating | 昆山一鼎工业科技有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-115976586-A | Positive and negative pulse electrolytic nickel-tungsten alloy solution, preparation method, electroplating method and nickel-tungsten alloy coating | 昆山一鼎工业科技有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-10399966-B2 | Compounds for treatment of trypanosomes and neurological pathogens and uses thereof | UNIVERSITY OF WASHINGTON (US) | 2019-09-03 | — | — | US | disclosed |
| US-20190031649-A1 | COMPOUNDS FOR TREATMENT OF TRYPANOSOMES AND NEUROLOGICAL PATHOGENS AND USES THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2019-01-31 | — | — | US | disclosed |
| EP-2346956-B1 | ACTIVATORS FOR TWO PART CYANOACRYLATE ADHESIVES | Henkel IP & Holding GmbH (DE) | 2017-12-06 | — | — | EP | disclosed |
| EP-2346956-B1 | ACTIVATORS FOR TWO PART CYANOACRYLATE ADHESIVES | Henkel IP & Holding GmbH (DE) | 2017-12-06 | — | — | EP | disclosed |
| WO-2017127627-A1 | COMPOUNDS FOR TREATMENT OF TRYPANOSOMES AND NEUROLOGICAL PATHOGENS AND USES THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2017-07-27 | — | — | WO | disclosed |
| EP-1377640-B1 | AZO COMPOUNDS AND PROCESS OF PRODUCING THE SAME AND NOVEL INTERMEDIATE COMPOUNDS USED IN THE PROCESS OF PRODUCING AZO COMPOUNDS | FUJIFILM CORP (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-8933168-B2 | Activators for two part cyanoacrylate adhesives | Henkel IP & Holding GmbH (DE) | 2015-01-13 | — | — | US | disclosed |
| US-20070039517-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJI PHOTO FILM CO., LTD. | 2007-02-22 | — | — | US | disclosed |
| US-20070039517-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJI PHOTO FILM CO., LTD. | 2007-02-22 | — | — | US | disclosed |
| US-7175268-B2 | Inkjet recording ink and inkjet recording method | FUJI PHOTO FILM CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-7175268-B2 | Inkjet recording ink and inkjet recording method | FUJI PHOTO FILM CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-20070007698-A1 | Method of producting three-dimensional model | FUJIFILM CORPORATION (JP) | 2007-01-11 | — | — | US | disclosed |
| US-20070007698-A1 | Method of producting three-dimensional model | FUJIFILM CORPORATION (JP) | 2007-01-11 | — | — | US | disclosed |
| EP-0116827-B1 | PROCESS FOR THE PREPARATION OF BENZOTHIAZOLES | BAYER AG (DE) | 1991-04-10 | — | — | EP | disclosed |
| US-4808723-A | Process for the preparation of benzothiazoles | BAYER AKTIENGESELLSCHAFT (DE) | 1989-02-28 | — | — | US | disclosed |
| EP-0116827-A2 | Process for the preparation of benzothiazoles | BAYER AG (DE) | 1984-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190031649-A1 | COMPOUNDS FOR TREATMENT OF TRYPANOSOMES AND NEUROLOGICAL PATHOGENS AND USES THEREOF | TSPO, GBA1, NLN | SMN1; SMN2 361/4885HTT 135/4885RIPK1 3345/4885 |
| US-10399966-B2 | Compounds for treatment of trypanosomes and neurological pathogens and uses thereof | TSPO, GBA1, NLN | SMN1; SMN2 361/4885HTT 135/4885RIPK1 3345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.